Dr. Poyurovsky has more than a decade of experience leading novel platforms and a track record of advancing therapies from concept to clinic. Prior to joining PMV, she was employed at Kadmon (acquired by Sanofi in 2021), most recently as Vice President, Discovery Biology.

Dr. Poyurovsky obtained a doctorate in biochemistry from Columbia University and a bachelor of science in biochemistry and biophysics from the University of Pittsburgh. During her time as a Research Scientist and a Postdoctoral Research Fellow at Columbia University, Dr. Poyurovsky conducted studies on p53 and Mdm2. She is the author and co-author of numerous publications and patents in the area of cancer biology and drug discovery.